chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient lost consciousness 5 minutes after administration of vaccine and hit his head on metal chair. Patient was sitting entire time. Paramedics and emergency personnel arrived and brought patient to emergency room.
Total body soreness and fatigue; Total body soreness and fatigue; 2. Fever like symptoms without fever; Cough sporadically; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170), via an unspecified route of administration in the left arm on 01May2021 at 09:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and diphenhydramine hydrochloride (BENADRYL); both started on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 19:00, the patient experienced total body soreness and fatigue, fever like symptoms without fever and cough sporadically. The clinical outcome of the events total body soreness and fatigue, fever like symptoms without fever and cough sporadically were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
The next day injection site was sore.; This is a spontaneous report from a contactable other healthcare professional (HCP). A 46-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) Lot number EL9265, via an unspecified route of administration on 31Jan2021 11:30 (at the age of 46 years old) as a SINGLE DOSE for covid-19 immunisation.  Medical history included asthma from an unknown date and unknown if ongoing, high blood pressure from an unknown date and unknown if ongoing.  Concomitant medication included amlodipine, montelukast sodium, fluticasone propionate, salmeterol xinafoate (ADVAIR) 500/50.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The vaccination was administered in a hospital. The patient experienced the next day injection site was sore on 01Feb2021.  The patient did not receive treatment. Outcome of event was recovered in 2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Swollen right elbow; Soft mass of something under the skin at the outside of the elbow. Very tender at first. Not so much now, but still reddish and swollen; Soft mass of something under the skin at the outside of the elbow. Very tender at first. Not so much now, but still reddish and swollen; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number not provided), via an unspecified route of administration in the right arm on 20Mar2021 at 09:15 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient received unspecified medications within 2 weeks of vaccination. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number not provided) via an unspecified route of administration in the right arm on 27Feb2021 at 19:30, (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not tested for COVID-19. On 20Mar2021 at 16:00, the patient experienced swollen right elbow, soft mass of something under the skin at the outside of the elbow which was very tender at first. The patient reported that the mass was reddish and swollen and not much tender at the time of the report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events.The clinical outcome of the events swollen elbow, tenderness and mass was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I had muscle pain in my arm the day of my vaccine (2/18/21) which lasted about 3 days. Then, I started having  pain near back/top of shoulder of injection arm (left). It?s like muscle pain that radiates near the side/back of my neck and hurts more with movement, turning over in bed, laying on that side, etc. The shoulder pain started around 10 pm on sat 2/20/21 and my vaccine was on Thursday 2/18/21.
This case was reported by a pharmacist and described the occurrence of headache in a 21 year old male subject who was vaccinated with Lyme disease vaccine recombinant for prophylaxis. Concurrent medical conditions included idiopathic thrombocytopenia purpura. Concurrent medications included Fluvoxamine and Tetracycline for unspecified drug indications. On an unspecified date in October 2000 the subject received the third dose of LYMErix. At an unspecified time after vaccination with LYMErix, on or after October 2000 and on or before 8/19/05, the subject experienced headache and fever and was hospitalized. The pharmacist reported that the subject, has positive IgG and IgM values. The outcome of the events was not provided.
Severe chills, fever, and whole body muscle ache. Symptoms began approximately 8 hours after injection and continued at a high level for 12 hours (overnight). Muscle aches and skin sensitivity continued into the day following but chills and fever subsided completely.
A dose of Pfizer Bivalent was administered to a client who had two Moderna doses prior. For the age group of client, bivalent should have been of Moderna brand as well. Client had no adverse reactions per parent.
Severe pain in upper left arm. (On scale 1-20, it was a 20), lasting 48 hours. Extremely painful to the point of almost going to the emergency room at local hospital. After first 48 hours pain remained, however ranges from 0 to 10. During the initial 24 hours, it required immobilizing my arm. Ibuprofen was ineffective. In addition, following the first 24 hours, I was not able to raise my arm beyond shoulder height for the next 48 hours. Pain continues to be present intermittently, daytime or while sleeping it reaches a level to awaken me. Treatment includes Ibuprofen and topical application of CBD. Sought mendial attention from PCP, OD.
p/v pt w/3hr of inconsolable crying;leg red & hot to touch thigh-knee;afeb;APAP given;cool compresses applied;
I do not know if this is related to the vaccination, however, since the vaccination my blood pressure has increased to a much higher level. I was running in the 120/80 - 130/90 range. I am now running in the 170/90 -190/100 range.  My doctor has increased my blood pressure medication to address this increase but I thought it best to report it.
The patient is a 76 y.o. female with history of HTN, SSS s/p pacemaker in 2012, PAF, and anxiety presented to the Hospital with chest pain with productive cough.   Acute hypoxic respiratory failure d/t Covid-19 infection   Gastroenteritis  Bronchitis  Received full immunization and 2 boosters, most recently on 10/17  RA on arrival, currently requiring 2L NC Afebrile, no leukocytosis On Decadron 6mg for 10 days CRP  TRENDING DOWN PRN mucinex and cough suppressants Encourage IS use Contact precautions On tele/pulse ox with goal SpO2 > 88-90% warfarin for DVT ppx PT/OT/SW consulted Weaned off from NC 02 as able, continue decadron for a total of 10 days, antitussive, PCP follow up. Monitor Pulse ox at home. IS  and Acapella   Atypical Chest Pain, unknown etiology Paroxysmal Atrial Fibrillation Elevated troponin  QT prolongation  Intermittent, episodic shooting chest pains similar to her previous symptomology of Afib Afebrile, no leukocytosis O2 saturation >94% on room air, no orthopnea  CBC unremarkable, Hgb stable at 13  Chem 7 shows mild hyponatremia (132) and hypokalemia (2.6) Last 2D echo July 2022 shows LVEF 55% +/- 5 with mild left ventricular concentric hypertrophy  Troponin elevated to 277, chronically elevated in the past, down trending w/o complaint of CP  CXR shows stable cardiomegaly, non-acute EKG shows atrial fibrillation with PVCs, rate of 90 Continuous cardiac monitoring Anticoagulation with warfarin to be continued on admission Cardiac diet  Repeat EKG   Essential HTN  Elevated BP to 160 SBP, ~80-90 DBP on admission Continue home metoprolol   Anxiety Continue home sertraline  Obesity  Body mass index is 35.09 kg/m². Discussed dietary and lifestyle modifications Consider nutrition consult    Severe hypokalemia, resolved  Mild hyponatremia, resolved  Potassium of 2.6 on admission, pt reported several episodes of diarrhea the past few days Sodium 132, continue to monitor with repeat labs and hydration  Cr stable at 0.63, eGFR 92  Received Covid-19 booster on Monday 10/17 Mag 1.5  EKG shows atrial fibrillation with PVCs, rate of 90 Replete potassium and monitor with repeat labs
Patient was given a dose of 0.5ml instead of 0.3ml. No immediate adverse reactions noted. Patient notified and advised to contact office with any adverse effects.
unconsolable high pitched crying & irritability lasting 8 hrs; no knot or fever;
Woke up with a huge left blood shot eye; Everything was so bright; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8730), via an unspecified route of administration in the left arm on 22Mar2021 at 17:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, laser surgery for a detached retina one and half years ago and allergy to latex gloves. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified concomitant medications within two weeks of vaccination. The patient previously received oxycodone; aspirin (PERCODAN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 22:00, the patient was watching television, and all of a sudden, she had to turn off the television and lights because everything was so bright and the patient went to bed. On 23Mar2021 at 06:30, the patient woke up with a huge left blood shot eye. It was reported that the patient had never experienced a blood shot eye before, and this was the eye she had laser surgery for a detached retina one and half years ago. The patient had just gone to retina doctor two weeks prior to the vaccine and her eye was doing great. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events everything was so bright and woke up with a huge left blood shot eye. The clinical outcomes of the events everything was so bright and woke up with a huge left blood shot eye were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a Doctor of pharmacy concerning a 65 year old female patient with no adverse events following prior vaccination who on 17-JAN-2011, at 11:30, was vaccinated subcutaneously with the first dose of ZOSTAVAX (Merck) (Lot number 669538/1390Z) and developed localized reaction, redness and swelling which resolved without treatment. The patient did not require an emergency room/doctor visit. There were no diagnostic tests or laboratory data. At the time of the report the patient had recovered. No further information is available.
COVID-19; COVID-19; Dose 1, 2 and 4:Moderna; Dose 3: Pfizer BioNTech vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 3 (booster), single (Lot number: FK9893) at the age of 54 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 12Feb2021 as dose 1, single (Lot number: 024M20A), in left arm, on 24Oct2021 as dose 2, single (Lot number: 040a21a), in left arm and on 06Sep2022 as dose 4 (booster), single (Lot number: As7140c), in left arm for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE; LORATADINE, stop date: 28Nov2022. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 07Apr2022, outcome "unknown", described as "Dose 1, 2 and 4:Moderna; Dose 3: Pfizer BioNTech vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.
Patient stated he was feeling "heavy", dizzy, nauseated and feeling chills prior to fainting. Once he was attended to, he was evaluated and taken to the local SEARHC ER. He was released a few hours later when his symptoms resolved. This patient had worked over two weeks straight with Herring as a seafood processor with little sleep and exhaustion.
Information has been received from a physician referring to multiple unspecified numbers of patients of unknown age and gender. The patients' concurrent condition, medical history and concomitant therapy were not reported. From January 2016, an unspecified number of patients were vaccinated with an improperly stored dose of VAQTA (lot#, expiration date, dosage, frequency and route were not reported) for prophylaxis. No adverse effect reported. The vaccine was stored at unspecified high or low temperature excursions from January 2016. The reporter stated that one refrigerator experienced 2041 excursions and another experienced 230 excursions during this timeframe. There has previous temperature excursion. Data logger was involved. No product quality complaint was involved. No further information was provided. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA008490: US-009507513-1709USA004627: US-009507513-1709USA004633: US-009507513-1709USA004630: US-009507513-1709USA004631: US-009507513-1709USA004628: US-009507513-1709USA004629.
At Approximately 10:31 am after receiving 3 shots, DTaP, IPV, MMR child fell backwards in Mom's arms.  Shaking, eyes rolled back in head, lasted 2-3 seconds.  Child breathing, nonresponsive 3-5 minutes.  Very pale, shaking stopped but remained nonresponsive 3-5 minutes, breathing without difficulty.  Vital signs P88, 84/60 weak but awake. Walked unsteadily.  EMTs came, Mom was going to transport and said she would take to doctor.  Left alert and oriented.  Rec'd  call from Mother - she left message @ 11:51.  Went home with child - tired and eating at this time.  Rec'd another message @ 4:26 pm, Mom did take child to doctor, was told pt fainted due to holding breath.  Doing fine now."
Patient fainted with loss of consciousness for about 10 seconds a few minutes after receiving the vaccine and waiting in waiting area. Patient regained consciousness without event, suffered mild nausea/vomiting.  Parents state this happens often, (with every vaccine or sight of blood).
chest pain, shortness of breath, wheezing, abdominal pain, anaphylaxis
This spontaneous report as received from a licensed nurse practitioner refers to a patient of unknown age. On 07-JUN-2018, the patient was vaccinated with improperly stored dose of ROTATEQ (lot # N026686, expiry date: 30-MAR-2019) (route: oral). The vaccine was exposed to a temperature of 47 F to 77 F at a time frame of 8 hours, 30 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects reported. The outcome of the events was unknown. This is one of the three reports received from the same reporter. Sender's Comments: US-009507513-1808USA001697: US-009507513-1808USA001701.
Vaccine is formulated for patients 60+ and pt was given the vaccine being under 60 years of age. Pt experienced no adverse reaction. Pt reports only a sore arm that resolved yesterday. Pt doing well. Pt was made aware of error.
Was having body aches everywhere so I got out of bed at 2:30am to take some ibuprofen. I started to feel lightheaded and started to get the cold sweats. Next this I know I?m waking up on the ground. I had passed out. I went to the ER and was diagnosed with syncope.  I wasn?t given any treatment after they identified  my EKG and vitals were normal and was discharged quickly.   I feel fine right now.
Very slight headache initially but went away after approximately one hour.  Rest of day I felt slightly energized.  The next day I felt a little tired.
3/7/03 IM tetanus toxoid given right arm. 3/8/03 PT reported hives all over body and itching. C/o being ill w/bronchitis, w/some S.O.B. via phone. Saw own MD, taking PO Benadryl and steroids PO ordered yet to start.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with GARDASIL. Subsequently the patient experienced dizziness and nausea within a few minutes post-vaccination. Unspecified medical attention was sought. It was reported that the symptoms lasted only a few minutes. Additional information has been requested.
During 2nd half of IM injection pt reported a "hot" sensation. Immed after withdrawal of Intact 25 1 1/4 inch needle pt had 1 cm x 1 cm warm induration & tenderness. By 10/1/12 pt had 3 cm x 3 cm hematoma. Began to resolve 10/2/12.
Patient experienced pain radiating down to the entire arm right after administration. Patient has not seek treatment yet. Patient was advised to get checkup with her doctor.
Second shot hurt and it was bleeding; Second shot hurt and it was bleeding; I got a very stiff neck on my left side and I cannot look over my shoulder on my left side; It hurts to hold my head up; My tongue is swollen and I end up biting and that is hurting; My tongue is swollen and I end up biting and that is hurting; My teeth even hurt; I have a headache in my temple area; My skin hurts when touched; I have weakness all over and it hurts to talk; My back hurts; I have a gland swelled right underneath my chin under my jaw; Nauseated; My diaphragm also hurts, it feels like I did 100 pushups or something; my eyes hurt; my hips hurt; my joint hurts; My hands hurt; This is spontaneous report received from contactable female consumer (Patient) reported for herself. A 69-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6205, Expiration date: unknown), via an unspecified route of administration in left arm on 26Mar2021 as single dose for COVID-19 immunization. Historical vaccine included received 1st dose of covid-19 vaccine (Lot number: EN6201) on unspecified date. Patient experienced second shot hurt and it was bleeding, got a very stiff neck on his left side and Patient cannot look over my shoulder on my left side; It hurts to hold my head up, tongue was swollen and I end up biting and that is hurting, his teeth even hurt, I have a headache in temple area, his skin hurts when touched, I have weakness all over and it hurts to talk, I have a gland swelled right underneath my chin under my jaw, back hurts, nauseated, diaphragm also hurts, it feels like I did 100 pushups or something, eyes hurt, hips and join hurt, hands hurt on 26Mar2021. Treatment was not given to the events. The outcome of events is known.  No follow-up attempts are needed. No further information is expected.
EYELIDS WERE INFLAMED; DIFFICULTY SLEEPING; FATIGUE; HEAD TINGLING; PERIPHERAL NEUROPATHY; ADVERSE EVENT; This spontaneous report received from a patient concerned a 55 year old adult female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 in JUN-2020, and concurrent conditions included: non-smoker. The patient had no history of drug abuse or illicit drug use. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 202A21A expiry: unknown) dose was not reported, 01 total administered on 29-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  The patient mentioned that, she had already contracted covid in JUN-2020, but took the shot for preventive purposes even though she had antibodies in December 2020. On 04-MAY-2021, the patient experienced adverse event. On 04-MAY-2021 patient had her wellness exam and she told the doctor that her head, feet and hands were tingling. She was told to give it 6-8 weeks to see if symptoms subside. The symptoms did not go away after 6 weeks and were getting worse. Her obstetrician-gynecologists (OBGYN) sent her to the primary care physician (PCP) and they did not give her much to help. In JUL-2021 patient went to a neurologist because her symptoms were getting progressively worse. Patient was going to a neurologist, acupuncturist and even an ophthalmologist because her eye lids were inflamed. She has had 3 magnetic resonance imaging tests (MRIs), a spinal tap, and among other tests with nothing was coming back positive. The patient was told that she is suffering from peripheral neuropathy. While she was getting better, it was still a struggle and it took an emotional and financial toll on her. The patient was treated with Gabapentin and Cymbalta. She had difficulty sleeping, and was fatigued.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from difficulty sleeping, and was recovering from adverse event, peripheral neuropathy, eyelids were inflamed, fatigue, and head tingling. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20211136843- COVID-19 VACCINE AD26.COV2.S-peripheral neuropathy. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Child was feeling fine after 15 minutes and went back to class. About 20-25 minutes later he felt itchy on his chin.  His eyes were slightly swollen and he had mild hives. School nurse gave him benadryl and mom came to pick him up.
He contacted the office on 10/21 to say he had a "rash" on his R upper arm.  He has 10 lesions that look like drying chicken pox on his upper right arm.  They are spaced 2-3 inches apart.  There 2 on lower arm and 1 on his R thumbs.  They are very itchy - no pain.  No fever of other illness.